Represents the amount of additional capital contributions to be made in the joint venture entity.

No definition available.

Name:	ontx_AdditionalCapitalContributionsInJointVenture
Namespace Prefix:	ontx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The percentage of ownership of equity participation in a consolidated joint venture.

+ References

No definition available.

+ Details

Name:	ontx_ConsolidatedJointVentureOwnershipPercentage
Namespace Prefix:	ontx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the amount of initial capital contribution in the joint venture entity.

+ References

No definition available.

+ Details

Name:	ontx_InitialCapitalContributionInJointVenture
Namespace Prefix:	ontx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the number of new programs to be collaborated and developed by the joint venture.

+ References

No definition available.

+ Details

Name:	ontx_NumberOfNewProgramsToBeCollaboratedAndDevelopedByJointVenture
Namespace Prefix:	ontx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683

+ Details

Name:	us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684

+ Details

Name:	us-gaap_GainLossOnSaleOfBusiness
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ontx_GBOLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=ontx_GVKBiosciencesPrivateLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Preclinical Collaboration (Details) $ in Thousands	1 Months Ended	3 Months Ended	12 Months Ended
Preclinical Collaboration (Details) $ in Thousands	Nov. 30, 2014 USD ($)	Jun. 30, 2018 USD ($) Program	Dec. 31, 2018 USD ($)	Dec. 31, 2013 USD ($) Program	Dec. 31, 2012 Program
Preclinical Collaboration
Gain on dissolution of GBO		$ 693	$ 824
Non-controlling interest portion upon consolidation		$ (163)	$ (163)
GBO
Preclinical Collaboration
Number of new programs to be collaborated and developed \| Program		2			2
Ownership interest in the joint venture (as a percent)				90.00%
GBO \| GVK BIO
Preclinical Collaboration
Number of new programs to be collaborated and developed \| Program				2
Initial capital contribution				$ 500
Ownership interest in the joint venture (as a percent)	17.50%			10.00%
Additional capital contributions	$ 500
GBO \| GVK BIO \| Minimum
Preclinical Collaboration
Ownership interest in the joint venture (as a percent)				10.00%
GBO \| GVK BIO \| Maximum
Preclinical Collaboration
Ownership interest in the joint venture (as a percent)				50.00%